News
Greycoat Research and Dr. Arai Toshiro collaborate on study on antioxidant effect of resveratrol
Greycoat Research and Dr. Arai Toshiro, a professor of feline veterinary medicine and an advisory expert for Greycoat Research, have begun conducting case studies on the antioxidant effect of resveratrol....
Greycoat Research and Dr. Arai Toshiro collaborate on study on antioxidant effect of resveratrol
Greycoat Research and Dr. Arai Toshiro, a professor of feline veterinary medicine and an advisory expert for Greycoat Research, have begun conducting case studies on the antioxidant effect of resveratrol....
New Study Highlights Resveratrol’s Role in Gut Health for Kidney Disease
A recent study published in the International Journal of Medical Sciences is drawing attention for its findings on resveratrol and its ability to protect the intestinal lining in the presence of...
New Study Highlights Resveratrol’s Role in Gut Health for Kidney Disease
A recent study published in the International Journal of Medical Sciences is drawing attention for its findings on resveratrol and its ability to protect the intestinal lining in the presence of...
Cat Kidney Disease Cure Nears Reality: Dr. Toru Miyazaki’s AIM Therapy Targets 2027
After decades of research, a potential cure for feline chronic kidney disease is finally within reach. The long-anticipated AIM injection drug is set to enter clinical trials in April, and...
Cat Kidney Disease Cure Nears Reality: Dr. Toru Miyazaki’s AIM Therapy Targets 2027
After decades of research, a potential cure for feline chronic kidney disease is finally within reach. The long-anticipated AIM injection drug is set to enter clinical trials in April, and...
Dr. Toru Miyazaki's AIM Drug Nears Trials as Survey Hits 550 Applicants
Dr. Toru Miyazaki, who discovered the AIM protein and uncovered its role in feline CKD, is currently conducting a blood test survey aimed at understanding the prevalence and stages of...
Dr. Toru Miyazaki's AIM Drug Nears Trials as Survey Hits 550 Applicants
Dr. Toru Miyazaki, who discovered the AIM protein and uncovered its role in feline CKD, is currently conducting a blood test survey aimed at understanding the prevalence and stages of...
Greycoat Research implements automated system for faster shipping
Greycoat Research has implemented a new automated shipping system to provide its customers faster, more reliable services.
Greycoat Research implements automated system for faster shipping
Greycoat Research has implemented a new automated shipping system to provide its customers faster, more reliable services.
Dr. Toru Miyazaki to begin clinical trials for new AIM drug
Dr. Toru Miyazaki—the pioneer behind AIM protein research—will be officially beginning clinical trials for a new AIM drug aimed at treating CKD in cats.
Dr. Toru Miyazaki to begin clinical trials for new AIM drug
Dr. Toru Miyazaki—the pioneer behind AIM protein research—will be officially beginning clinical trials for a new AIM drug aimed at treating CKD in cats.